Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 4/2015

01-04-2015 | Specific Populations and Emerging Markets (V Dilsizian and T Schindler, Section Editors)

Relatively High Prevalence of Takotsubo Cardiomyopathy (Stress-Induced Cardiomyopathy) in the Japanese Population—Contribution of Cardiac Imaging in the Identification of Takotsubo Cardiomyopathy and its Differentiation from Acute Coronary Syndrome

Authors: Keiichiro Yoshinaga, Yuuki Tomiyama, Mamoru Sakakibara, Keisuke Takeuchi, Nagara Tamaki

Published in: Current Cardiovascular Imaging Reports | Issue 4/2015

Login to get access

Abstract

Apical ballooning syndrome, the so-called takotsubo cardiomyopathy (TTC), is characterized by wall-motion abnormality. The wall-motion abnormality includes hypokinesis in the mid and apical segments of the left ventricle (LV) with hyperkinesis in the mid LV segment. The LV dysfunction is reversible. TTC has been reportedly been found in 1 to 2 % of patients suspected of having acute coronary syndrome (ACS). Although the wall-motion abnormality of TTC is a significant feature, clinical presentation involving chest pain or ECG abnormalities is similar to that for ACS. Therefore, the diagnosis of TTC is still a challenge in emergency settings. Cardiovascular imaging may assist in the diagnosis and understanding of the pathophysiology of TTC.

Literature
    1. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. N Engl J Med. 1966;274:1102–8.View ArticlePubMed
    2. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation. 2008;118:397–409.View ArticlePubMed
    3. Yoshinaga K, Torii H, Tahara M. A serial echocardiographic observation of acute heart injury associated with pheochromocytoma crisis. Int J Cardiol. 1998;66:199–202.View ArticlePubMed
    4. Shaw TR, Rafferty P, Tait GW. Transient shock and myocardial impairment caused by phaeochromocytoma crisis. Br Heart J. 1987;57:194–8.View ArticlePubMed CentralPubMed
    5. Bybee KA, Kara T, Prasad A, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141:858–65.View ArticlePubMed
    6. Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in Japan. J Am Coll Cardiol. 2001;38:11–8.View ArticlePubMed
    7. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118:2754–62.View ArticlePubMed
    8. Madhavan M, Rihal CS, Lerman A, Prasad A. Acute heart failure in apical ballooning syndrome (TakoTsubo/stress cardiomyopathy): clinical correlates and Mayo Clinic risk score. J Am Coll Cardiol. 2011;57:1400–1.View ArticlePubMed
    9. Scantlebury DC, Prasad A. Diagnosis of Takotsubo cardiomyopathy. Circ J: Off J Jpn Circ Soc. 2014;78:2129–39.View Article
    10. Kurowski V, Kaiser A, von Hof K, et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest. 2007;132:809–16.View ArticlePubMed
    11. Prasad A, Dangas G, Srinivasan M, et al. Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: an analysis from a multicenter, international study of ST-elevation myocardial infarction. Catheter Cardiovasc Interv: Off J Soc Card Angiogr Interv. 2014;83:343–8. This study revealed the frequency of TTC in patients with suspected ACS.View Article
    12. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–16.View ArticlePubMed
    13. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006;27:1523–9.View ArticlePubMed
    14. Watanabe H, Kodama M, Okura Y, et al. Impact of earthquakes on Takotsubo cardiomyopathy. JAMA. 2005;294:305–7.View ArticlePubMed
    15. Zarifeh JA, Mulder RT, Kerr AJ, Chan CW, Bridgman PG. Psychology of earthquake-induced stress cardiomyopathy, myocardial infarction and non-cardiac chest pain. Intern Med J. 2012;42:369–73.View ArticlePubMed
    16. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:e1–e157.View ArticlePubMed
    17. Kurisu S, Kihara Y. Clinical management of takotsubo cardiomyopathy. Circ J: Off J Jpn Circ Soc. 2014;78:1559–66.View Article
    18. Subramanyam S, Kreisberg RA. Pheochromocytoma: a cause of ST-segment elevation myocardial infarction, transient left ventricular dysfunction, and takotsubo cardiomyopathy. Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2012;18:e77–80.View Article
    19. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665–75.View ArticlePubMed
    20. Yoshinaga K, Oriuchi N, Wakabayashi H, et al. (2014) Effects and safety of I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry. Endocr J. 2014;61:1171–80.
    21. Frustaci A, Loperfido F, Gentiloni N, Caldarulo M, Morgante E, Russo MA. Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study. Chest. 1991;99:382–5.View ArticlePubMed
    22. Attar MN, Moulik PK, Salem GD, Rose EL, Khaleeli AA. Phaeochromocytoma presenting as dilated cardiomyopathy. Int J Clin Pract. 2003;57:547–8.PubMed
    23. Galetta F, Franzoni F, Bernini G, et al. Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomed Pharmacother Biomedecine pharmacotherapie. 2010;64:505–9.View Article
    24. Giammarile F, Chiti A, Lassmann M, Brans B, Flux G. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008;35:1039–47.View ArticlePubMed
    25. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–48.View ArticlePubMed
    26. Yoshinaga K, Manabe O, Tamaki N. Assessment of coronary endothelial function using PET. J Nucl Cardiol. 2011;18:486–500.View ArticlePubMed
    27. Patel SM, Lerman A, Lennon RJ, Prasad A. Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy). Eur Heart J Acute Cardiovasc Care. 2013;2:147–52. This study added the new insight of pathopysiology of TTC such as microvascular endothelial dysfunction.View ArticlePubMed CentralPubMed
    28. Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol. 2010;56:1840–6.View ArticlePubMed CentralPubMed
    29. Dib C, Asirvatham S, Elesber A, Rihal C, Friedman P, Prasad A. Clinical correlates and prognostic significance of electrocardiographic abnormalities in apical ballooning syndrome (Takotsubo/stress-induced cardiomyopathy). Am Heart J. 2009;157:933–8.View ArticlePubMed
    30. Sharkey SW, Lesser JR, Menon M, Parpart M, Maron MS, Maron BJ. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction. Am J Cardiol. 2008;101:1723–8.View ArticlePubMed
    31. Kosuge M, Ebina T, Hibi K, et al. Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol. 2010;55:2514–6.View ArticlePubMed
    32. Lee JW, Kim JY. Stress-induced cardiomyopathy: the role of echocardiography. J Cardiovasc Ultrason. 2011;19:7–12.View Article
    33. Citro R, Rigo F, D’Andrea A, et al. Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. JACC Cardiovasc Imaging. 2014;7:119–29. This article addressed that the important echocardiographic parameters and their association with outcomes in TTC.View ArticlePubMed
    34. Yoshinaga K, Chow BJ, dekemp RA, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des. 2005;11:903–32.View ArticlePubMed
    35. Yoshinaga K, Tamaki N. Imaging myocardial metabolism. Curr Opin Biotechnol. 2007;18:52–9.View ArticlePubMed
    36. Yoshinaga K, Tomiyama Y, Suzuki E, Tamaki N. Myocardial blood flow quantification using positron-emission tomography: analysis and practice in the clinical setting. Circ J: Off J Jpn Circ Soc. 2013;77:1662–71.View Article
    37. Udelson JE, Beshansky JR, Ballin DS, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA. 2002;288:2693–700.View ArticlePubMed
    38. Testa M, Feola M. Usefulness of myocardial positron emission tomography/nuclear imaging in Takotsubo cardiomyopathy. World J Radiol. 2014;6:502–6. This review briefly summarized research developments of PET in patients with TTC.View ArticlePubMed CentralPubMed
    39. Ito K, Sugihara H, Kinoshita N, Azuma A, Matsubara H. Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT. Ann Nucl Med. 2005;19:435–45.View ArticlePubMed
    40. Feola M, Rosso GL, Casasso F, et al. Reversible inverse mismatch in transient left ventricular apical ballooning: perfusion/metabolism positron emission tomography imaging. J Nucl Cardiol. 2006;13:587–90.View ArticlePubMed
    41. Cimarelli S, Sauer F, Morel O, Ohlmann P, Constantinesco A, Imperiale A. Transient left ventricular dysfunction syndrome: patho-physiological bases through nuclear medicine imaging. Int J Cardiol. 2010;144:212–8.View ArticlePubMed
    42. Dunet V, Qanadli SD, Allenbach G, et al. Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography. Circ J: Off J Jpn Circ Soc. 2012;76:160–7.View Article
    43. Yoshinaga K, Manabe O, Katoh C, et al. Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET. Eur J Nucl Med Mol Imaging. 2010;37:2233–41.View ArticlePubMed
    44. Owa M, Aizawa K, Urasawa N, et al. Emotional stress-induced ‘ampulla cardiomyopathy’: discrepancy between the metabolic and sympathetic innervation imaging performed during the recovery course. Jpn Circ J. 2001;65:349–52.View ArticlePubMed
    45. Kurisu S, Inoue I, Kawagoe T, et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo-like left ventricular dysfunction. J Am Coll Cardiol. 2003;41:743–8.View ArticlePubMed
    46. Guidelines for clinical use of cardiac nuclear medicine (JCS 2010)—digest version. Circ J: Off J Jpn Circ Soc. 2012;76:761–7.
    47. Matsuo S, Nakajima K, Kinuya S, Yamagishi M. Diagnostic utility of 123I-BMIPP imaging in patients with Takotsubo cardiomyopathy. J Cardiol. 2014;64:49–56.View ArticlePubMed
    48. Bybee KA, Murphy J, Prasad A, et al. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. J Nucl Cardiol. 2006;13:244–50.View ArticlePubMed
    49. Yoshida T, Hibino T, Kako N, et al. A pathophysiologic study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography. Eur Heart J. 2007;28:2598–604.View ArticlePubMed
    50. Morel O, Sauer F, Imperiale A, et al. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail. 2009;15:206–13.View ArticlePubMed
    51. Ohira H, Tsujino I, Yoshinaga K. (1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011;38:1773–83.View ArticlePubMed
    52. Ishida Y, Yoshinaga K, Miyagawa M, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med. 2014;28:393–403.View ArticlePubMed
    53. Suga K, Tsukamoto K, Nishigauchi K, et al. Iodine-123-MIBG imaging in pheochromocytoma with cardiomyopathy and pulmonary edema. J Nucl Med. 1996;37:1361–4.PubMed
    54. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Musha H, Sasaka K. 123I-MIBG myocardial scintigraphy in patients with “takotsubo” cardiomyopathy. J Nucl Med. 2004;45:1121–7.PubMed
    55. Prasad A, Madhavan M, Chareonthaitawee P. Cardiac sympathetic activity in stress-induced (Takotsubo) cardiomyopathy. Nat Rev Cardiol. 2009;6:430–4.View ArticlePubMed
    56. Tamaki N, Kuge Y, Yoshinaga K. Molecular imaging in heart failure patients. Clin Transl Imaging: Rev Nucl Med Mol Imaging. 2013;1:341–51.View Article
    57. Yoshinaga K, Tomiyama Y, Manabe O, et al. Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT. Ann Nucl Med. 2014;28:761–9.View ArticlePubMed
    58. Leurent G, Larralde A, Boulmier D, et al. Cardiac MRI studies of transient left ventricular apical ballooning syndrome (takotsubo cardiomyopathy): a systematic review. Int J Cardiol. 2009;135:146–9.View ArticlePubMed
    59. Sharkey SW, Windenburg DC, Lesser JR, et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55:333–41.View ArticlePubMed
    60. Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011;306:277–86.PubMed
    61. Eitel I, Behrendt F, Schindler K, et al. Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur Heart J. 2008;29:2651–9.View ArticlePubMed
Metadata
Title
Relatively High Prevalence of Takotsubo Cardiomyopathy (Stress-Induced Cardiomyopathy) in the Japanese Population—Contribution of Cardiac Imaging in the Identification of Takotsubo Cardiomyopathy and its Differentiation from Acute Coronary Syndrome
Authors
Keiichiro Yoshinaga
Yuuki Tomiyama
Mamoru Sakakibara
Keisuke Takeuchi
Nagara Tamaki
Publication date
01-04-2015
Publisher
Springer US
Published in
Current Cardiovascular Imaging Reports / Issue 4/2015
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-015-9328-y

Other articles of this Issue 4/2015

Current Cardiovascular Imaging Reports 4/2015 Go to the issue

Molecular Imaging (R Russell, Section Editor)

Application of Cardiac Neurohormonal Imaging to Heart Failure, Transplantation, and Diabetes

Intravascular Imaging (I-K Jang, Section Editor)

Dye-Staining Angioscopy for Coronary Artery Disease

Specific Populations and Emerging Markets (V Dilsizian and T Schindler, Section Editor)

Cardiac Imaging in Latin America: Chagas Heart Disease

Specific Populations and Emerging Markets (V Dilsizian and T Schindler, Section Editors)

State of Overall Cardiovascular Risk and Imaging Strategies in India

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits